Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

BIZARRE: Zimmer biomet s q3 2025 earnings what to expect - What They Never Told You

With a market cap of $18.4 billion, Indiana-based Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology leader specializing in musculoskeletal healthcare. The company designs, manufactures, and markets a broad portfolio of orthopedic reconstructive implants, sports medicine and trauma products, dental solutions, and surgical technologies, including robotic-assisted systems. 

The company is slated to announce its fiscal Q4 2025 results soon. Ahead of the event, analysts expect Zimmer Biomet to report an adjusted EPS of $2.38, up 3% from $2.31 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in each of the past four quarterly reports while missing on another occasion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.